Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;5 Suppl 4(Suppl 4):S407-12.
doi: 10.3978/j.issn.2072-1439.2013.08.15.

Intensive care unit and lung cancer: when should we intubate?

Affiliations
Review

Intensive care unit and lung cancer: when should we intubate?

Paul Zarogoulidis et al. J Thorac Dis. 2013 Sep.

Abstract

Lung cancer still remains the leading cause of cancer death among males. Several new methodologies are being used in the everyday practise for diagnosis and staging. Novel targeted therapies are being used and others are being investigated. However; early diagnosis still remains the cornerstone for efficient treatment and disease management. Lung cancer patients requires in many situations intensive care unit (ICU) admission, either due to the necessity for supportive care until efficient disease symptom control (respiratory distress due to malignant pleural effusion) or disease adverse effect management (massive pulmonary embolism). In any case guidelines indicating the patient that has to be intubated have not yet been issued. In the current review we will present current data and finally present an algorithm based on the current published information for lung cancer patients that will probably benefit from admission to the ICU.

Keywords: Intensive care unit (ICU); lung cancer; respiratory distress.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ma J, Ward EM, Smith R, et al. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer 2013;119:1381-5 - PubMed
    1. Darwiche K, Freitag L, Nair A, et al. Evaluation of a novel endobronchial ultrasound-guided lymph node forceps in enlarged mediastinal lymph nodes. Respiration 2013;86:229-36 - PubMed
    1. Darwiche K, Baumbach JI, Sommerwerck U, et al. Bronchoscopically obtained volatile biomarkers in lung cancer. Lung 2011;189:445-52 - PubMed
    1. Fuchs FS, Zirlik S, Hildner K, et al. Confocal laser endomicroscopy for diagnosing lung cancer in vivo. Eur Respir J 2013;41:1401-8 - PubMed
    1. Boutsikou E, Kontakiotis T, Zarogoulidis P, et al. Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer. Onco Targets Ther 2013;6:125-34 - PMC - PubMed